Aripiprazole (Q34203550)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Aripiprazole	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Aripiprazole. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Michelle A Grady

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Timothy L Gasperoni

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Peter Kirkpatrick

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

427-428

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Catching up on schizophrenia: natural history and neurobiology

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1114

31 March 2020

Identifiers

10.1038/NRD1114

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34203550&oldid=2196377384"